Powered by AI-driven M&A and PE exits, 2025 is on pace to be the strongest year for large deals since 2021 and second strongest year in history for large deals.
- 100 results
- Reset filters
Loading...
GenAI and deepfakes are helping e-commerce fraudsters evade detection across the customer life cycle. Learn how you can build legal resilience without adding customer friction.
The OBBB Act reinforces the government’s push for domestication of investment while offering clarity and permanence in key areas of corporate taxation.
C-suite leaders now recognize divestitures as a strategic move that can refocus resources in a changing business environment.
Help guide providers, payers, pharma companies and employers as they determine medical cost trends and the factors driving or dampening spending in 2026.
Surprise, surprise: Winning M&A strategies for turbulent times. For all the surprises, deals are getting done, as dealmakers navigate today’s market.
We believe an upswing is still possible, but it’s unlikely without more policy clarity and stability.
Dealmakers have adopted a careful yet strategic approach, poised to seize opportunities as favorable conditions emerge.
Companies are responding with targeted mitigation strategies, while maintaining flexibility as tariff policies continue to evolve.
While deal volume decreased, the increase in announced deal value indicates sustained investor demand for perceived stability of the overall insurance market.
We continue to be optimistic about the second half of the year, as we emerge from uncertainty caused by tariffs and other policy changes.
Despite macroeconomic uncertainties, AWM businesses remain guardedly optimistic about the opportunities presented by recent market disruption.
The IPO market has shown moderate signs of life, with high profile names filing and a handful of new public offerings.
Health services M&A has weathered a complicated macroeconomic and political environment but, strong subsector growth demonstrates sector durability.
Even with ongoing uncertainty around tariffs, rising costs and shifting consumer demand, companies are still doing deals — they're just being more careful.
Despite strong investor appetite and a desire to put capital to work, many sponsors grapple with how to unlock value in a high cost of capital environment.
Loading...
Our insights. Your choices.
Subscribe to Deals insights
Follow us
